Fate Therapeutics Inc 10-K for FY2024
Fate Therapeutics Inc (FATE)
10-K
2025-03-05
For: 2024-12-31
View Original
Added on
April 06, 2026
About this 10-K
Fate Therapeutics Inc filed this 10-K on March 5, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $13.63M
- down 78.5% from $63.53M a year earlier
- Net loss
- $186.26M
- compared with a net loss of $160.93M a year earlier
- Diluted EPS
- -$1.64
- compared with -$1.64 a year earlier